Single- and multi-tablet HIV regimens go head-to-head
MDSpire News
August 26, 2026
You now have access to the trusted editorial news and specialty content you've known from the Conexiant news site—all within the MDSpire experience.
Learn more

Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Affiliations:
Specialties:
Areas of Expertise:
5 Topic Commentaries
Single- and multi-tablet HIV regimens go head-to-head
David R. Bangsberg, MD, MPH
Infectious Diseases, HIV Medicine
•University of California, San Francisco (UCSF) and San Francisco General Hospital Medical Center
Joyce L. Jones, MD, MS
Infectious Diseases, HIV Medicine
•Johns Hopkins University School of Medicine
Stacey A. Rizza, MD
Infectious Diseases, HIV Medicine
•Mayo Clinic
Paul E. Sax, MD
Infectious Diseases, HIV Medicine
•Brigham and Women’s Hospital and Harvard Medical School
Adam Spivak, MD
Infectious Diseases, HIV Medicine
•University of Utah School of Medicine
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.